A rating of 33 puts Phio Pharmaceuticals Corp (PHIO) near the middle of the Biotechnology industry according to InvestorsObserver. Phio Pharmaceuticals Corp's score of 33 means it scores higher than 33% of stocks in the industry. Phio Pharmaceuticals Corp also received an overall rating of 33, putting it above 33% of all stocks. Biotechnology is ranked 116 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 33 would rank higher than 33 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Phio Pharmaceuticals Corp Stock Today?
Phio Pharmaceuticals Corp (PHIO) stock has fallen -9.49% while the S&P 500 is higher by 1.2% as of 12:09 PM on Thursday, May 13. PHIO has fallen -$0.19 from the previous closing price of $2.05 on volume of 929,779 shares. Over the past year the S&P 500 has risen 45.81% while PHIO has fallen -15.07%. PHIO lost -$1.92 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Phio Pharmaceuticals Corp (PHIO) Stock.
